Bortezomib/Cyclophosphamide/Daratumumab/Dexamethasone Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bortezomib, cyclophosphamide, daratumumab and dexamethasone that can be used for the treatment of plasma cell (multiple) myeloma and systemic light chain amyloidosis.

**Synonyms:** - Bortezomib-Cyclophosphamide-Daratumumab-Dexamethasone - Bortezomib-Cyclophosphamide-Daratumumab-Dexamethasone Regimen - Bortezomib-Cyclophosphamide-Dexamethasone Plus Daratumumab - Bortezomib/Cyclophosphamide/Daratumumab/Dexamethasone - Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab - Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab Regimen - Bortezomib/Cyclophosphamide/Dexamethasone Plus Darzalex - CyBorD-Daratumumab - Daratumumab-CyBorD - VCD-Daratumumab